carmustine has been researched along with Respiration Disorders in 1 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Respiration Disorders: Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Symptomatic pulmonary disease occurred in 20 per cent of 93 patients with anaplastic gliomas being treated with carmustine (BCNU)." | 3.66 | Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: an assessment of risk factors. ( Aronin, PA; Donohue, JF; Dudka, L; Mahaley, MS; Moore, P; Rudnick, SA; Selker, RG, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aronin, PA | 1 |
| Mahaley, MS | 1 |
| Rudnick, SA | 1 |
| Dudka, L | 1 |
| Donohue, JF | 1 |
| Selker, RG | 1 |
| Moore, P | 1 |
1 other study available for carmustine and Respiration Disorders
| Article | Year |
|---|---|
Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: an assessment of risk factors.
Topics: Adult; Analysis of Variance; Bone Marrow; Carmustine; Child; Drug Therapy, Combination; Female; Glio | 1980 |